IP Library Granted Patent US 9,387,123
Granted Patent B2
US 9,387,123 · App. 14/255,121 · Granted Jul 12, 2016

System and method for determining dosimetry in ophthalmic photomedicine

Inventors: Daniel V. Palanker (Sunnyvale, CA); Dan Andersen (Menlo Park, CA)
Assignee: Topcon Medical Laser Systems, Inc.
A61F9/008A61B18/20A61F9/00821A61B19/5212A61B2018/2085A61F2009/00855A61F2009/00863A61F2009/00868A61F2009/00897
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,387,123
App. No.
14/255,121
Granted
Jul 12, 2016
Kind
B2
Abstract

A system and method for treating ophthalmic target tissue, including a light source for generating a beam of light, a beam delivery system that includes a scanner for generating patterns, and a controller for controlling the light source and delivery system to create a dosimetry pattern of the light beam on the ophthalmic target tissue. One or more dosage parameters of the light beam vary within the dosimetry pattern, to create varying exposures on the target tissue. A visualization device observes lesions formed on the ophthalmic target tissue by the dosimetry pattern. The controller selects dosage parameters for the treatment beam based upon the lesions resulting from the dosimetry pattern, either automatically or in response to user input, so that a desired clinical effect is achieved by selecting the character of the lesions as determined by the dosimetry pattern lesions.

Claims (22)

1. A method for treating ophthalmic target tissue, comprising:

generating a beam of light using a light source;

delivering the beam of light to ophthalmic target tissue using a beam delivery unit having a scanner unit for deflecting the beam of light;

creating a dosimetry pattern of the beam of light on the ophthalmic target tissue for which at least one dosage parameter of the beam of light varies within the dosimetry pattern;

observing lesions formed on the ophthalmic target tissue by the dosimetry pattern;

entering information about the observed lesions using a user interface that is connected to a controller that controls at least one of the light source and the beam delivery unit;

selecting at least one dosage parameter for the beam of light in response to the entered information; and

controlling at least one of the light source and the beam delivery unit using the controller to then deliver the beam of light having the selected at least one dosage parameter to the ophthalmic target tissue.

2. The method of claim 1 , wherein the selecting comprises determining one of the lesions has a particular visible clinical result.

3. The method of claim 1 , wherein the selecting comprises determining a number of lesions present on the ophthalmic target tissue.

4. The method of claim 1 , wherein the delivering of the beam of light having the selected at least one dosage parameter further comprises creating a treatment pattern of the beam of light on the ophthalmic target tissue.

5. The method of claim 4 , wherein the creating of the treatment pattern of the beam of light on the ophthalmic target tissue further comprises producing invisible lesions on the ophthalmic target tissue and producing at least one visible lesion that serves as a fiducial mark for visually locating the invisible lesions.

6. The method of claim 1 , further comprising:

displaying a visual indicator on the user interface which visually indicates a desired clinical result of a lesion to be produced by the beam of light on the ophthalmic target tissue.

7. The method of claim 6 , wherein the desired clinical result is at least one of an intensity and size of a lesion produced by the beam of light.

8. The method of claim 6 , further comprising:

adjusting at least one dosage parameter of the beam of light in response to user input on the user interface.

9. The method of claim 6 , further comprising:

measuring a clinical result of a lesion produced by the beam of light on the ophthalmic target tissue; and

displaying an additional visual indicator that visually indicates the measured clinical result.

10. The method of claim 1 , wherein the beam of light is pulsed, and wherein the dosimetry pattern comprises a plurality of discrete spots.

11. The method of claim 1 , wherein the dosimetry pattern comprises a moving spot that scans a straight or curved line.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2021
From: TOPCON MEDICAL LASER SYSTEMS, INC.
To: IRIDEX CORPORATION
Reel/Frame 056836/0849 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2014
From: PALANKER, DANIEL V.; ANDERSEN, DAN
To: TOPCON MEDICAL LASER SYSTEMS, INC.
Reel/Frame 032711/0001 →
Continuity (4)
Division 13691687 · Nov 30, 2012
Division 11939398 · Nov 13, 2007
Provisional Application 60857951 · Nov 10, 2006
Related Publication 20140228823A1 · Aug 14, 2014